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Objectives: The Netherlands is known for a stringent search and destroy policy to prevent spread of MRSA. In the
hospital setting, livestock-associated MRSA (LA-MRSA) is frequently found in patients coming from the high density
farming area in the south of the Netherlands. The aim of the study was to determine the contribution of LA-MRSA
in the epidemiology of MRSA in cases found following the Dutch search and destroy policy.
Patients and methods: From two hospitals serving a population of 550,000 persons all data on MRSA cultures and
subsequent control measures from 2008 and 2009 were retrospectively collected and analyzed.
Results: A total of 3856 potential index patients were screened for MRSA, 373 (9.7%) were found to be positive, 292
( 78%) LA-MRSA and 81 (22%) non-LA-MRSA respectively. No secondary cases were found among contact research
in persons exposed to LA-MRSA (0/416), whereas similar contact research for non-LA-MRSA resulted in 83 (2.5%)
secondary cases. LA-MRSA were rarely found to cause infections.
Conclusions: LA-MRSA is more prevalent than non-LA-MRSA in Dutch Hospitals in the South of the Netherlands.
However, retrospectively studied cases show that the transmission rate for LA-MRSA was much lower than for
non-LA-MRSA. This suggest that infection control practices for LA-MRSA may possibly be less stringent than for
non-LA-MRSA.
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The Netherlands is known for a stringent search and
destroy policy to prevent spread of MRSA in care facil-
ities. According to the Dutch MRSA guideline for hospi-
tals (www.wip.nl), patients at risk for being a carrier are
screened for MRSA at admission. Defined risk groups
are: known MRSA carriers, patients hospitalised abroad,
or contacts of known MRSA carriers. Since june 2006,
persons in close contact with pigs and veal before hos-
pital admission have been included in the guideline, as-
suming equal clinical significance between LA-MRSA
and healthcare-associated MRSA (HA-MRSA). When
being admitted, asymptomatic MRSA carriers are treated
in isolation to prevent transmission. The percentage of
LA-MRSA among all isolates sent in to the national* Correspondence: p.schneeberger@jbz.nl
3Department of Medical Microbiology and Infection Control, Jeroen Bosch
Hospital, PO Box 90153, ‘s-Hertogenbosch 5200 ME, The Netherlands
Full list of author information is available at the end of the article
© 2015 van de Sande-Bruinsma et al.; licensee
the Creative Commons Attribution License (ht
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.MRSA surveillance in the Netherlands is about 40%
annualy [1]. Especially in the South of the Netherlands
where the highest concentrations of livestock animal
farming can be found, a high prevalence of LA-MRSA is
assumed to lead to considerable increased workload and
infection control precautions in hospitals. Still, in contrast
to non-LA-MRSA, severe infections due to LA-MRSA
seem to be rare [2] and the justification of these precau-
tion efforts can be questioned.
The aim of this epidemiological study was to determine
the prevalence of LA-MRSA and the contribution of
LA-MRSA to the total epidemiology of MRSA patients
screened conform the search and destroy policy in a high
density farming area in the South of the Netherlands.
Furthermore, we evaluated the relative clinical relevance
and risk of transmission of LA-MRSA by comparing the
transmission rate and infection rate of LA-MRSA and
non-LA-MRSA.BioMed Central. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Study design
From the laboratory information system of the regional
laboratory in Den Bosch located in a high density farm-
ing area in the South of the Netherlands (serving 2 hos-
pitals, general practitioners and nursing homes and a
population of about 550.000 persons), the test results of
all screening cultures performed per patient for MRSA
detection from 2008 and 2009 were collected.
In case of a MRSA positive result the following infor-
mation was obtained: i) indication for MRSA screening
i.e. according to the risk group categories of the MRSA
guideline (www.wip.nl), ii) the institution where the
culture was taken ((general practice, nursing home, out-
patient department, first aid department, hospital), iii)
the spa typing results from the national MRSA surveil-
lance discriminating LA-MRSA (ST398) and non-LA-
MRSA. If the MRSA was isolated from a clinical sample
the medical records from the hospital information system
were retrieved.
The clinical relevance of the culture was based on the
material (blood, wound, urine) the isolate was cultured
from. A MRSA carrier was defined as a patient being colo-
nized and/or infected (superficial or deep infection) with
MRSA. In case of transmission subsequent secondary
contact tracing was attributed to the index case.
An index case was a patient that was found MRSA
positive and resulted in contact research. Secondary cases
were patients that were found MRSA positive during con-
tact research of an index patient.
Statistical methods
Characteristics of patients and isolates were analysed.
Differences in percentages were tested with a Chi-square
test or Fisher’s exact test, if appropriate.
Results
Detection of MRSA
In total 10,233 primary screening cultures from 3856
unique patients for MRSA were taken in the period
2008–2009. For 25% of the 3856 screened patients the
indication of screening was available. From this group
26% of the patients were screened as they reported pro-
fessional contact with pigs and or veal calves and 64%
were screened for risk carrying non-LA-MRSA (i.e. con-
tact with a non-LA-MRSA positive patient or recent ad-
mission in a high risk hospital) In total 373 (9.7%) of the
3856 patients were found to be colonized with MRSA
through primary screening Of these, 292 (78%) were
LA-MRSA and 81 (22%) were non-LA-MRSA (Figure 1).
Forty-two patients with LA-MRSA and 43 patients with
non-LA-MRSA carriage resulted in contact research of
416 and 3381 patients and personnel respectively (second-
ary screening). No secondary cases were found among thecontact research conducted for LA-MRSA patients (0/
416), whereas the contact research of the non-LA-MRSA
patients resulted in 83 (2.5%) secondary non-LA-MRSA
cases (Figure 1).
Thirty patients were unexpectedly detected as MRSA
carriers, when clinical cultures were taken. These infec-
tions were most likely community acquired, as none could
be linked to a known index case. Six patients had an infec-
tion with a LA-MRSA strains (25%).
Overall, via primary (373) and secondary screening
(83) and regular clinical culture (30), 486 patients were
found to be MRSA carrier in 2008 and 2009 together
(Figure 1).
Indication of screening
In Figure 2 the indication of screening for the MRSA
positive patients is displayed, making a distinction be-
tween LA-MRSA (n = 292) and non-LA-MRSA (n = 81)
patients. The patients with MRSA detected through sec-
ondary screening (n = 83) fall within the ‘contact MRSA’
column of non-LA-MRSA. A large diversity in the charac-
teristics of the patients carrying LA-MRSA versus non-
LA-MRSA was found (Table 1).
MRSA infections
During the study period, 39 patients had a MRSA infec-
tion (Figure 1). Seven of these infections were caused by
LA-MRSA (Table 2). Only the first case, depicted in
Table 2, was screened at forehand due to contact with
pigs, and was therefore a known carrier. The 6 other
LA-MRSA infections were unexpected findings and
could not directly be linked to close contact with pigs.
The spa types of the LA-MRSA isolates causing clinical
infections were mainly dispersed among the most frequent
spa types (t108, t011, t11) detected overall. In the 2 year
study period no bacteraemia caused by a LA-MRSA was
found and none of the patients died because of the LA-
MRSA infection.
Of the 32 infections caused by non-LA-MRSA (Figure 1),
8 were known carriers through 113 screening and the
remaining 24 non-LA-MRSA infections were unexpected
findings. The majority were wound infections (50%) and
abscesses (22%). Two non-LA-MRSA strains, that were
both spa type t179, caused a bacteraemia. Both of these
patients were not screened for MRSA. The spa types of
the non-LA-MRSA isolates causing clinical infections
were mainly dispersed among the most frequent spa
types (t179, t002, t002, t311, t316, t008) detected over-
all. None of the patients died because of the non-LA-
MRSA infection.
Discussion
In this study, 59% of the detected MRSA carriers in
2008 and 2009, were colonized with LA-MRSA. The
Primary screening: 3856 pts Clinical samples: 36.300 pts
MRSA carriage: 373 pts S.aureus infection: 3303 pts
LA-MRSA carriage: 292 pts non-LA-MRSA carriage: 81 pts MRSA infection: 30 pts 
42/292 index pts 43/81 index pts
LA-MRSA infection: 6 pts non-LA-MRSA infections: 24 pts 
Secondary screening: 416 pts Secondary screening: 3381 pts Screening + Clinical sampling:
Total MRSA = 486 pts 
LA-MRSA carriage: 0 pts non-LA-MRSA carriage: 83 pts Total LA-MRSA = 298 pts
Total non-LA-MRSA = 188 pts
LA-MRSA carriage: 292 pts non-LA-MRSA carriage: 164 pts Total LA-MRSA infection = 7 pts
Total non-LA-MRSA infection = 32 pts
LA-MRSA infection: 1 pt non-LA-MRSA infection: 8 pts


































Figure 2 Indication of screening of the MRSA positive patients.
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Table 1 Patient characteristics of the patients colonized





Male* 214 (72%) 84 (45%)
<= 15 years 21 (7%) 16 (9%)
>15 - < 65 years* 255 (86%) 99 (53%)
> = 65 years* 22 (7%) 73 (39%)
Colonized 291 (98%) 154 (82%)
Superficial infection* 3 (1%) 8 (5%)
Deep infection* 4 (1.3%) 24 (13%)
GP* 120 (40%) 47 (25%)
Nursing resident* 4 (1.3%) 82 (44%)
First aid* 41 (14%) 8 (4%)
Outpatient department* 64 (21%) 13 (7%)
Hospitalized* 20 (7%) 27 (14%)
Outpatient department
or Hospitalized*
35 (12%) 5 (3%)
*p < =0.05.
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screening, were screened because of close contact with
pigs and veal calves, contributing to 23% of the MRSA
positive cultures, compared to 9% positive cultures for
the other screening indications. These figures under-
score the additional workload and costs related to imple-
mentation of the search and destroy measures caused by
LA-MRSA in a high density farming area in the South of
the Netherlands. Even though the majority of LA-MRSA
was directly linked to close contact with pigs, LA-MRSA
was also frequently found among patients that were
screened for close contact with other livestock animals.
Moreover, LA-MRSA was also found accidentally amongTable 2 Medical history of the 7 patients with a LA-MRSA infe
Pt Age/gender/Spa type Type of infection Treatment
1 40/male/t011 External otitis Surgical cleansing, n
antibiotic treatment
2 90/male/t567 Pleural empya Surgical drainage,
quinelones and rifam
3 41/male/t011 Abscess finger Incision and drainag
antibiotic treatment
4 89/male/t108 Abcess tooth/jaw Incision and drainag
no antibiotic treatme
5 60/male/t108 Wound infection of
lymphnode biopsie
No specific treatmen
6 80/female/t011 Conjunctivitis Topical antibiotics
(fusidinic acid)
7 40/female/t011 Toe wound Numerous antibioticpatients without known contact with livestock, when
they were screened for other reasons such as a contact
with an known MRSA carrier (10%; 12/124, not related to
outbreak investigation), MRSA carriage within the family
(45%; 5/11) or hospitalization abroad (17%; 2/12) (Figure 2).
Clearly, livestock and in particular pigs are an important
reservoir of MRSA in the Netherlands [3-9], that should be
closely monitored and possibilities to reduce transmission
to humans should be investigated. However, our results in
line with the findings of others that LA-MRSA is not solely
attributed to close or direct contact with livestock, but in
some cases may have dispersed in a community where
the density of pig farms is high [10]. This adds to the
increasing number of reports which found LA-MRSA
isolated from patients in hospitals among individuals
without known contact with livestock [11-15].
A major limitation of this study was the relatively large
group of MRSA positive patients without a known indi-
cation for screening (n = 62, 13%), even after additional
inquiry of the treating physician that requested the screen-
ing. Moreover, the majority (84%) of the patients with an
unknown indication of screening carried LA-MRSA,
suggesting that part of them failed to report contact with
livestock. Questionnaires to register the risk group were
submitted by the treating specialists. More than one risk
factor was only sporadically indicated, suggesting a bias by
under recording multiple risk factors.
During the 2 year study period an equal number of LA-
MRSA and non-LA-MRSA index patients were indentified.
In case of transmission, subsequent secondary contact tra-
cing was attributed to the index case, and the sesecondary
cases resulted in additional contacts which had to be
screened. No secondary cases were found for LA-MRSA,
whereas 84 secondary cases were found during the contact
research for non-LA-MRSA. Consequently, for contactction
Animal contact Extra
o Pig farmer Cured
pin
None Post infectious sterile pleural effusion,
surgically drained and secondarily
infected through drain (colonized)
with LA-MRSA




t Horse farm T cell lymphoma, wound infection cured
None Conjunctivitis occurred during stay on
ICU for gram negative urosepsis.
Conjunctivitis cured
s None Wound occurred after a visit to Turkey.
Wound cured.
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personnel were screened, compared to 80 patients and
personnel for each non-LA-MRSA contact. Individuals col-
onized with LA-MRSA are significantly less likely to trans-
mit LA-MRSA to other individuals in the hospital setting
compared to non-LA-MRSA [2,16]. We realize that sec-
ondary cases based on contact history and SPA typing my
overestimate the actual number of secondary cases.
In a study performed in Dutch hospitals, LA-MRSA
was found 4–6 times less transmissible than non-LA-
MRSA [17,18]. After artificial inoculation LA-MRSA is
capable to colonize the human nose for a prolonged
period, however Van Cleef et al. showed that after short-
term occupational exposure LA-MRSA was frequently
present, but in most cases the strain was lost again after
24 hours [19,20]. This failure to actually colonize their
host under certain circumstances may further explain
the lower chance to transmit LA-MRSA.
Nevertheless, in contrast to our finding, outbreaks of
LA-MRSA can occur in hospital and other health care set-
tings [21,22]. However in nursing homes infection control
practices may be less stringent than in hospitals [22].
It has been suggested that LA-MRSA may not cause
as much disease as non-LA-MRSA strains [2]. Several
studies have found that ST398 typically lacks many pre-
viously identified toxin genes [23-26], including the PVL
gene, though pvl positive ST398 have been reported
[4,25,27]. In the present study, 39 infections with MRSA
were reported of which 7 were caused by LA-MRSA
(18%). Only one of the 7 infected patients was screened
at forehand due to close contact with pigs. The other six
were detected through clinical sampling.
As mentioned earlier, only one of the 7 patients with a
LA-MRSA infection had been screened at forehand.
Among the 6 patients that were not screened at fore-
hand, one turned out to be a butcher and one a horse
farmer. The other 4 patients had no known contact with
livestock. The butcher had cut his hand with a knife at
his butchery and the horse farmer also had a wound
infection. The Dutch Food Safety Agency has sampled
various kinds of meat collected from retail trade. MRSA
was isolated from 12% of the 2217 samples analyzed and
the majority (85%) belonged to ST398 [8]. Several other
studies from all over the world have also found MRSA
in retail meat samples. Even though the chance of
colonization with MRSA for professionals handling raw
meat is low [28] it could be a plausible explanation in
the Butcher’s case. The number of reports on MRSA
colonization and infections in horses is increasing and
varies between 0% and 4.7% on horse farms in Europe,
Canada and North America [29-32]. In a recent study
from the Netherlands, a suspected transmission of MRSA
ST398 between a horse and a girl, resulting in a foot
infection, was described [33].A remarkable finding of the present study was that the
majority of MRSA infections was found unexpectedly
and was not among the screened patients with a known
risk for MRSA. This supports the idea that MRSA in gen-
eral is increasingly found outside the known reservoirs. In
a study published by Lekkerkerk et al [34], the emergence
of MRSA with no link to established Dutch risk factors for
acquisition, hampering early detection and control, is
described. They reported that from the Dutch national
MRSA surveillance at least 24% of the 5565 MRSA iso-
lates registered were not from a defined risk group and
that studies on new sources and transmissions are ur-
gently needed to control the spread of MRSA [34].
In conclusion, in the Netherlands, MRSA carriage and
infection remains a rare finding, reflecting the success of
the “Dutch” search and destroy policy. Although LA-
MRSA appears to have a very limited impact on clinical
disease and hospital transmission it does require exten-
sive control measures which may effect the operation of
control measures for non-LA-MRSA, especially in an area
where the density of pig-farms and the prevalence of LA-
MRSA is likely to be high.
If the transmission rate and infectious capabilities of
LA-MRSA stay stable over time, rapid laboratory identifi-
cation of LA-MRSA can facilitate infection control by
rapidly distinguishing LA from non-LA-MRSA. Possibly,
in hospitals control measures for LA-MRSA may be less
stringent compared to non-LA-MRSA, since LA-MRSA
does spread in the community but rarely seems to spread
in hospitals.
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